Protective role of green tea polyphenols against paraquat induced oxidative stress in rat liver

Author(s):  
Sabah G El-Banna
Nutrients ◽  
2018 ◽  
Vol 10 (7) ◽  
pp. 834 ◽  
Author(s):  
Sajid Rahman ◽  
Yingying Huang ◽  
Lei Zhu ◽  
Shibin Feng ◽  
Ibrar Khan ◽  
...  

2005 ◽  
Vol 5 (9) ◽  
pp. 1397-1405 ◽  
Author(s):  
Rita Rezzani ◽  
Barbara Buffoli ◽  
Luigi Rodella ◽  
Alessandra Stacchiotti ◽  
Rossella Bianchi

2010 ◽  
Vol 88 (16) ◽  
pp. 3644-3655 ◽  
Author(s):  
Usha Gundimeda ◽  
Thomas H. McNeill ◽  
Jason E. Schiffman ◽  
David R. Hinton ◽  
Rayudu Gopalakrishna

2006 ◽  
Vol 291 (1-2) ◽  
pp. 155-160 ◽  
Author(s):  
Mehmet Sahin ◽  
Hakan Cam ◽  
Seref Olgar ◽  
Sevket Ercan Tunc ◽  
Cagatay Arslan ◽  
...  

2007 ◽  
Vol 41 (1) ◽  
pp. 16-22 ◽  
Author(s):  
B. Madhan ◽  
G. Krishnamoorthy ◽  
J. Raghava Rao ◽  
Balachandran Unni Nair

2005 ◽  
Vol 156 (2-3) ◽  
pp. 101-111 ◽  
Author(s):  
Anil K Bansal ◽  
Manju Bansal ◽  
Giridhar Soni ◽  
Deepak Bhatnagar

Author(s):  
Howard H. Bailey ◽  
Hasan Mukhtar

Green tea, which has higher concentrations of polyphenols than other teas, has been correlated with reduced risk of various malignancies with most data supporting a potential protective role in prostate neoplasia. Preclinical studies over the last 25 years implicate constituent green tea catechins, epigallocatechin-3-gallate (EGCG) being the predominant form, as the main mechanistic ingredient in the observed biologic effects, which vary from proapoptotic effects to inhibition of androgen receptor and signal transduction pathways. There have been few prospective clinical trials of green tea polyphenols (GTP), especially with well-characterized formulations and doses. Although there have been hints of beneficial clinical activity in prostate neoplasia, other studies have raised concerns about the limited bioavailability and very low target-tissue concentrations of GTPs. At present there is no proven role for GTP supplementation in the prevention of genitourinary (GU) malignancies, but novel GTP formulations and further clinical testing may still support a future for GTP supplementation in GU cancer prevention.


Sign in / Sign up

Export Citation Format

Share Document